FIELD: medicine.
SUBSTANCE: in 10-14 days following a surgical removal of a tumour in a patient, daily urine is analysed for sex hormones: oestradiol and pregnandiol. Then, they are related to each other. If the value exceeds 0.8, the onset of metastases or a recurrent disease for the following one and a half or two years is predicted. If the relation is less than 0.8, a metastases-free and recurrence-free period for more than 8-10 years is predicted.
EFFECT: use of the declared method allows determining the early onset of metastases or recurrence after combinatory treatment.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DETERMINING EFFICIENCY OF TREATMENT OF UTERINE BODY CANCER | 2010 |
|
RU2424806C1 |
| METHOD FOR PREDICTION OF RECURRENT CARCINOMA OF VULVA | 2013 |
|
RU2532342C1 |
| METHOD FOR PREDICTING RELAPSE OF MAMMARY CANCER | 2003 |
|
RU2263319C2 |
| METHOD FOR PREDICTING RELAPSES IN SKIN MELANOMA PATIENTS | 2004 |
|
RU2275637C2 |
| METHOD FOR PREDICTION OF RECURRENT VULVAR CANCER | 2013 |
|
RU2517541C1 |
| METHOD OF PREDICTING DURATION OF RECURRENCE-FREE PERIOD IN RADICALLY TREATED PATIENTS WITH MAMMARY GLAND CANCER | 2009 |
|
RU2413231C2 |
| METHOD OF FORECASTING OF AUTOHEMOCHEMIOTHERAPY EFFICIENCY AT PATIENTS WITH RELAPSES AND METASTASISES OF UTERUS NECK CANCER | 2007 |
|
RU2352942C1 |
| METHOD FOR PREDICTING THE DURATION OF RELAPSE-FREE PERIOD IN PATIENTS WITH MAMMARY CANCER | 2003 |
|
RU2251692C2 |
| METHOD FOR PREDICTING THE EFFICIENCY OF CHEMOTHERAPY IN PATIENTS WITH UTERINE CHORIOCARCINOMA | 2006 |
|
RU2315321C2 |
| METHOD FOR PREDICTION OF RECURRENT OVARIAN CARCINOMA | 2013 |
|
RU2530556C1 |
